IL-33 receptor ST2 is also highly expressed in the nasal mucosa of patients with AR or CRS [57,58,59], suggesting that IL-33/ST2 may play an important role in the pathogenesis of allergic nasal diseases. Here, IL33 is linked to congenital rubella syndrome.